ANGELA WINSTEAD: Open Payments
NPI 1033515267 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,751 in 62 payments from 19 companies in 2025. Trend: 2023 $571 · 2024 $658 · 2025 $1,751
Food & beverage: $1,751
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $325 |
| Eisai Inc. | 5 | $235 |
| Dexcom, Inc. | 5 | $210 |
| Inspire Medical Systems, Inc. | 3 | $188 |
| GlaxoSmithKline, LLC. | 7 | $164 |
| Corcept Therapeutics | 5 | $116 |
| Novo Nordisk Inc | 6 | $109 |
| Xeris Pharmaceuticals, Inc. | 4 | $69 |
| Abbott Laboratories | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
Products named: EVENITY, Leqembi, INSPIRE, DEXCOM G7 GSS (161), Korlym, TRELEGY ELLIPTA, Dexcom G6 Transmitter, SHINGRIX.
Industry payments across TX — which companies pay providers there.
